R0L.F J Frontier Co.,Ltd.

Healthcare Pharmaceutical Retailers Frankfurt Exchange
10.40 EUR
Close of Nov 12, 2026
6.25 18.40
Market cap
EUR 55.5M
P/E
-
P/B
8.18x
ROE
-3.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Aug 2026.

Is R0L.F undervalued?

Graham number

The Graham number of J Frontier Co.,Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

J Frontier Co.,Ltd. fundamental analysis

No fundamental analysis for J Frontier Co.,Ltd. yet.

J Frontier Co.,Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About J Frontier Co.,Ltd.

J Frontier Co.,Ltd. engages in the healthcare sales, medical care sales, and healthcare marketing businesses in Japan. It operates SOKUYAKU, one-stop service platform that provides online medical consultations, medication guidance, prescription drug delivery, and digital transformation support for medical institutions. The company also sells health, beauty, education, healing, medicine, and healthcare products, as well as health food through mail order; and provides product …

Full company profile